Investigation on the Potential Correlation Between TP53 and Esophageal Cancer

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• TP53 family members are crucial in human cancers.
• Their specific roles in esophageal cancer (ESCA) remain largely undefined.
• Understanding these roles is vital for targeted therapies.

Purpose of the Study:

• To investigate the gene expression, prognostic significance, and underlying mechanisms of TP53 family members in ESCA.
• To explore the functional impact of TP53 on esophageal squamous cell carcinoma (ESCC) progression.
• To elucidate the relationship between TP53 and the mTOR signaling pathway.

Main Methods:

• Utilized TCGA, TIMER, Kaplan-Meier plotter, GSEA, and UALCAN databases for expression and survival analysis.
• Validated TP53 expression via qRT-PCR.
• Assessed ESCC cell migration and proliferation using Transwell, scratch, and crystal violet assays.
• Evaluated TP53-mTOR pathway correlation via Western blotting.

Main Results:

• High mRNA expression of TP53 family members (TP53, TP63, TP73) correlated with advanced clinical stages and nodal metastasis in ESCA.
• TP53 expression was significantly associated with overall survival (OS) in ESCA patients.
• Downregulated TP53 expression in ESCC cells reduced migration and proliferation, potentially activating mTOR signaling and inhibiting TP53-dependent autophagy.

Conclusions:

• TP53 holds significant prognostic value in esophageal cancer.
• TP53 may function as a key driver in the pathogenesis of ESCA.
• Targeting TP53 could offer a therapeutic strategy for ESCA treatment.